非凡中國(08032.HK)年度純利45.63億港元 同比增長282.6%
格隆匯3月18日丨非凡中國(08032.HK)發佈公吿,截至2021年12月31日止年度,公司收益13.82億港元,同比增長68.7%;公司擁有人應占溢利45.63億港元,同比增長282.6%;每股盈利40.39港仙。
收益增長透過LNG品牌的內生型增長和於2020年七月下旬收購堡獅龍國際集團有限公司為集團多品牌鞋服消費品業務帶來的貢獻,加上運動體驗分部業務自疫情中恢復。
溢利大幅增加乃主要由於i)本期間出售一間聯營公司的部分權益而產生的收益達33.39億港元(2020年:10.23億港元),及ii)減少一間聯營公司的0.5%股權產生的視作攤薄收益9.78億港元(2020年:零港元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.